Montastruc JL - Search Results

1

Bagheri H, Laroche ML, Montastruc JL. Bagheri H, et al. Among authors: montastruc jl. Therapie. 2016 Apr;71(2):121-2. doi: 10.1016/j.therap.2016.02.019. Epub 2016 Feb 10. Therapie. 2016. PMID: 27080828 English, French. No abstract available.

2

[Role of adverse effects of immuno-allergic nature at a Regional Pharmacovigilance Center].

Sorbette F, Conte S, Montastruc JL. Sorbette F, et al. Among authors: montastruc jl. Therapie. 1992 Sep-Oct;47(5):445-6. Therapie. 1992. PMID: 1299998 French. No abstract available.

3

[Is there any desensitization of presynaptic alpha 2-adrenergic receptors in hypertension? Experimental and clinical studies].

Damase-Michel C, Tavernier G, Llau ME, Chollet F, Sénard JM, Bagheri H, Tran MA, Houin G, Guiraud-Chaumeil B, Montastruc JL, et al. Damase-Michel C, et al. Among authors: montastruc jl. Arch Mal Coeur Vaiss. 1992 Aug;85(8):1149-51. Arch Mal Coeur Vaiss. 1992. PMID: 1362344 French.

4

Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.

Bagheri H, Schmitt L, Berlan M, Montastruc JL. Bagheri H, et al. Among authors: montastruc jl. Br J Clin Pharmacol. 1992 Dec;34(6):555-8. doi: 10.1111/j.1365-2125.1992.tb05661.x. Br J Clin Pharmacol. 1992. PMID: 1362888 Free PMC article. Clinical Trial.

5

Is yohimbine-induced increase in salivary secretion a kinin-dependent mechanism?

Bagheri H, Bompart G, Girolami JP, Montastruc JL, Montastruc P. Bagheri H, et al. Among authors: montastruc jl, montastruc p. Fundam Clin Pharmacol. 1992;6(1):17-20. doi: 10.1111/j.1472-8206.1992.tb00089.x. Fundam Clin Pharmacol. 1992. PMID: 1372876

6

Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.

Montastruc JL, Rascol O, Senard JM, Gualano V, Bagheri H, Houin G, Lees A, Rascol A. Montastruc JL, et al. Clin Neuropharmacol. 1991 Oct;14(5):432-7. doi: 10.1097/00002826-199110000-00007. Clin Neuropharmacol. 1991. PMID: 1742752

7

[Evaluation of the pharmacovigilance follow-up of zidovudine].

Gimenez S, Bagheri H, Marchou B, Massip P, Lafont J, Sorbette F, Armengaud M, Montastruc JL. Gimenez S, et al. Among authors: montastruc jl. Therapie. 1990 Sep-Oct;45(5):407-9. Therapie. 1990. PMID: 2260033 French.

8

Yohimbine and lacrimal secretion.

Bagheri H, Berlan M, Montastruc JL, Montastruc P. Bagheri H, et al. Among authors: montastruc jl, montastruc p. Br J Clin Pharmacol. 1990 Jul;30(1):151-2. doi: 10.1111/j.1365-2125.1990.tb03757.x. Br J Clin Pharmacol. 1990. PMID: 2390426 Free PMC article. Clinical Trial. No abstract available.

9

Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.

Bagheri H, Chale JJ, Guyen LN, Tran MA, Berlan M, Montastruc JL. Bagheri H, et al. Among authors: montastruc jl. Fundam Clin Pharmacol. 1995;9(3):248-54. doi: 10.1111/j.1472-8206.1995.tb00292.x. Fundam Clin Pharmacol. 1995. PMID: 7557820

10

[Drug vigilance: opinion survey among residents of a university hospital].

Graille V, Lapeyre-Mestre M, Montastruc JL. Graille V, et al. Among authors: montastruc jl. Therapie. 1994 Sep-Oct;49(5):451-4. Therapie. 1994. PMID: 7855763 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

898 results

Search Page

Filters